We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-2.17%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$520M
AUM Growth
-$27.7M
Cap. Flow
-$13.6M
Cap. Flow %
-2.62%
Top 10 Hldgs %
32.77%
Holding
158
New
6
Increased
21
Reduced
108
Closed
10

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.7M
2
MMM icon
3M
MMM
+$3.69M
3
DRC
DRESSER-RAND GROUP INC
DRC
+$3.31M
4
DO
Diamond Offshore Drilling
DO
+$2.88M
5
INTC icon
Intel
INTC
+$2.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.16%
2 Industrials 19.16%
3 Technology 17.92%
4 Energy 8.19%
5 Utilities 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
26
Duke Energy
DUK
$101B
$5.75M 1.11%
76,884
-2,367
-3% -$173K
DRC
27
DELISTED
DRESSER-RAND GROUP INC
DRC
$5.69M 1.09%
69,199
-49,186
-42% -$3.31M
NEE icon
28
NextEra Energy
NEE
$186B
$5.47M 1.05%
233,200
-6,292
-3% -$152K
OTTR icon
29
Otter Tail
OTTR
$3.93B
$5.45M 1.05%
204,428
+67,050
+49% +$1.9M
EWS icon
30
iShares MSCI Singapore ETF
EWS
$1.03B
$5.05M 0.97%
189,163
-7,330
-4% -$202K
MMM icon
31
3M
MMM
$94.1B
$4.89M 0.94%
41,263
-30,678
-43% -$3.69M
EXC icon
32
Exelon
EXC
$48.4B
$4.79M 0.92%
197,023
+95,273
+94% +$2.23M
MDT icon
33
Medtronic
MDT
$111B
$4.53M 0.87%
73,183
-1,900
-3% -$121K
POR icon
34
Portland General Electric
POR
$5.92B
$4.47M 0.86%
139,085
-5,300
-4% -$176K
LLY icon
35
Eli Lilly
LLY
$1.09T
$4.46M 0.86%
68,788
-1,000
-1% -$63.3K
TMO icon
36
Thermo Fisher Scientific
TMO
$214B
$4.38M 0.84%
35,950
-1,100
-3% -$134K
AMAT icon
37
Applied Materials
AMAT
$378B
$4M 0.77%
185,310
-5,620
-3% -$124K
AAPL icon
38
Apple
AAPL
$4.99T
$3.99M 0.77%
158,504
+896
+0.6% +$22K
TT icon
39
Trane Technologies
TT
$104B
$3.78M 0.73%
67,020
+3,800
+6% +$230K
PG icon
40
Procter & Gamble
PG
$347B
$3.77M 0.73%
45,042
-1,755
-4% -$144K
MDU icon
41
MDU Resources
MDU
$4.31B
$3.69M 0.71%
348,854
-8,021
-2% -$95.5K
ADI icon
42
Analog Devices
ADI
$178B
$3.6M 0.69%
72,701
-2,175
-3% -$111K
OVV icon
43
Ovintiv
OVV
$16.4B
$3.58M 0.69%
33,780
-3,240
-9% -$357K
CYT
44
DELISTED
CYTEC INDS INC
CYT
$3.54M 0.68%
+74,750
New +$3.83M
EMC
45
DELISTED
EMC CORPORATION
EMC
$3.5M 0.67%
119,595
-3,125
-3% -$90.2K
ITRI icon
46
Itron
ITRI
$4.75B
$3.46M 0.67%
87,950
+800
+0.9% +$32K
EEM icon
47
iShares MSCI Emerging Markets ETF
EEM
$28B
$3.45M 0.66%
82,950
-2,450
-3% -$108K
FLS icon
48
Flowserve
FLS
$9.38B
$3.37M 0.65%
47,815
-1,250
-3% -$92.6K
SIAL
49
DELISTED
SIGMA - ALDRICH CORP
SIAL
$3.35M 0.64%
24,600
-23,375
-49% -$2.48M
DIS icon
50
Walt Disney
DIS
$172B
$3.31M 0.64%
37,152
-1,225
-3% -$108K

Similar funds

John G. Ullman & Associates's Q3 2014 Portfolio in Review

As of Q3 2014, John G. Ullman & Associates held 158 positions worth $520M, down 5.1% from $548M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q3 2014 filing shows 6 new, 21 increased, 108 reduced and 10 closed positions. Its largest new stake was CYTEC INDS INC: 74,750 shares worth $3.54M. The largest sale was Microsoft, an estimated $4.7M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q3 2014 buy was CYTEC INDS INC: 74,750 shares worth $3.54M.
  • John G. Ullman & Associates added most to iShares MSCI Emerging Markets Min Vol Factor ETF in Q3 2014, an estimated $2.4M increase.
  • John G. Ullman & Associates's biggest Q3 2014 reduction was Microsoft, cutting an estimated $4.7M.
  • John G. Ullman & Associates fully exited Diamond Offshore Drilling in Q3 2014, selling an estimated $2.88M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $520M portfolio in Q3 2014.
  • John G. Ullman & Associates opened 6 new positions and closed 10 in Q3 2014.
  • John G. Ullman & Associates's portfolio value fell 5.1% quarter-over-quarter to $520M.

Based on John G. Ullman & Associates's 13F filing for Q3 2014, filed 12 Nov 2014.